Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells

[1]  G. Ouyang,et al.  Cancer stem cells: a potential target for cancer therapy , 2015, Cellular and Molecular Life Sciences.

[2]  Susanta Bandyopadhyay,et al.  Transgenic analysis of GFAP promoter elements , 2013, Glia.

[3]  Lei Zhao,et al.  Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis , 2013, BMC Gastroenterology.

[4]  H. Zhen,et al.  Targeting role of glioma stem cells for glioblastoma multiforme. , 2013, Current medicinal chemistry.

[5]  Shinn-Zong Lin,et al.  Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme , 2013, Cell transplantation.

[6]  Mohammad Mohammadianpanah,et al.  Treatment outcome and prognostic factors of adult glioblastoma multiforme. , 2013, Journal of the Egyptian National Cancer Institute.

[7]  C. Kang,et al.  Down-regulation of miR-106b suppresses the growth of human glioma cells , 2013, Journal of Neuro-Oncology.

[8]  J. Sørensen,et al.  Clinical impact of ki-67 labeling index in non-small cell lung cancer. , 2013, Lung cancer.

[9]  C. Brennan,et al.  Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. , 2012, Cancer research.

[10]  J. Baehring,et al.  Glioblastoma multiforme: overview of current treatment and future perspectives. , 2012, Hematology/oncology clinics of North America.

[11]  I. Yang,et al.  CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme. , 2012, Neurosurgery clinics of North America.

[12]  Pierre-Marie Martin,et al.  Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review , 2011, Breast Cancer Research and Treatment.

[13]  O. Sampetrean,et al.  Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. , 2011, Neoplasia.

[14]  H. Zhang,et al.  Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor , 2011, Brain Research.

[15]  D. Gomez-Nicola,et al.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System , 2011, Clinical Medicine Insights. Oncology.

[16]  G. Maira,et al.  Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. , 2010, International journal of oncology.

[17]  M. Russo,et al.  Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma , 2011, Journal of Neuroinflammation.

[18]  Hongyang Zhao,et al.  Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells , 2010, Brain Research.

[19]  Michael Sabel,et al.  Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival , 2009, Clinical Cancer Research.

[20]  Haifeng Zhao,et al.  Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance–associated protein genes , 2008, Neuroscience.

[21]  Hongyang Zhao,et al.  Paradoxical Expression of Anti-Apoptotic and MRP Genes on Cancer Stem-Like Cell Isolated from TJ905 Glioblastoma Multiforme Cell Line , 2008, Cancer investigation.

[22]  Xiangpeng Yuan,et al.  Brain tumor stem cells: new targets for clinical treatments? , 2006, Neurosurgical focus.